3.06

42.70% -2.28

After Hours: 3.16 0.10 +3.27%

Organogenesis Holdings Inc (ORGO)

Overview News Price History Option Chain Financials Discussions Forecast

Organogenesis Holdings Inc stock is traded at $3.06, with a volume of 11.21M. It is down -42.70% in the last 24 hours and down -25.00% over the past month. Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Previous Close:

$5.34

Open:

$4.55

24h Volume:

11.21M

Relative Volume:

5.02

Market Cap:

$669.79M

Revenue:

$433.14M

Net Income/Loss:

$4.95M

P/E Ratio:

85.71

EPS:

0.0357

Net Cash Flow:

$6.55M

1W Performance:

-42.05%

1M Performance:

-25.00%

6M Performance:

-6.71%

1Y Performance:

+34.21%

1-Day Range:

$2.90

$4.55

1-Week Range:

$2.90

$5.55

52-Week Range:

$2.28

$6.71

Organogenesis Holdings Inc Stock (ORGO) Company Profile

Name

Organogenesis Holdings Inc

Sector

Healthcare (1153)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

781-575-0775

Address

85 DAN ROAD, CANTON, MA

Employee

869

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

ORGO's Discussions on Twitter

Compare ORGO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ORGO Organogenesis Holdings Inc	3.06	669.79M	433.14M	4.95M	6.55M	0.0357
ZTS Zoetis Inc	159.27	70.23B	9.29B	2.52B	2.28B	5.57
HLN Haleon Plc Adr	10.74	48.23B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.36	48.22B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	16.93	18.57B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	301.42	13.29B	2.76B	1.11B	898.10M	22.77

Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-28-24	Initiated	Lake Street	Buy
Feb-07-24	Initiated	Cantor Fitzgerald	Overweight
Jun-15-23	Initiated	Morgan Stanley	Equal-Weight
May-24-23	Upgrade	BTIG Research	Neutral → Buy
Nov-10-22	Downgrade	BTIG Research	Buy → Neutral
Aug-10-22	Downgrade	Oppenheimer	Outperform → Perform
Jan-10-20	Initiated	SVB Leerink	Outperform
Aug-26-19	Resumed	Credit Suisse	Outperform
May-02-19	Initiated	Credit Suisse	Outperform
Apr-17-19	Initiated	Oppenheimer	Outperform
Apr-11-19	Initiated	SunTrust	Buy

View All

Organogenesis Holdings Inc Stock (ORGO) Latest News

08:29 AM

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2025 Earnings Call Transcript - Insider Monkey

08:29 AM

03:26 AM

CLASS ACTION REMINDER: Kessler Topaz Meltzer & Check, LLP Reminds Organogenesis Holdings Inc. (ORGO) Shareholders of Securities Fraud Class Action Lawsuit - ACCESS Newswire

03:26 AM

02:41 AM

38,341 Shares in Organogenesis Holdings Inc. (NASDAQ:ORGO) Bought by Mariner LLC - Defense World

May 09, 2025

Earnings call transcript: Organogenesis Q1 2025 sees revenue drop, stock plummets - Investing.com

May 09, 2025

Organogenesis Reports Q1 2025 Financial Results - TipRanks

May 09, 2025

May 08, 2025

ORGO Reveals FY25 Adjusted EBITDA Outlook and ReNu Development Progress | ORGO Stock News - GuruFocus

May 08, 2025

Organogenesis Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025

Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results - The Manila Times

May 08, 2025

May 07, 2025

Daily Market Movement: Organogenesis Holdings Inc (ORGO) Sees a -2.26 Decrease, Closing at 5.20 - DWinneX

May 07, 2025